William C. Stewart, M.D. – Development Strategist
Dr. Stewart, co-founder, CEO and Medical Director, provides through PRN Pharmaceutical Research Network, LLC a vast knowledge in ophthalmic clinical practice, clinical research, pharmaceutical development and financing experience to assist a new or established company with their ophthalmic research needs. Dr. Stewart is also co-founder of PRN PharmaFarm, LLC.
As a researcher, Dr. Stewart has been a principal investigator in numerous ophthalmic studies. He is the author of a medical text, Clinical Practice of Glaucoma (Slack, Inc, 1990), and is a contributing author to 11 ophthalmology texts and monographs. Dr. Stewart has published over 400 peer reviewed articles and letters primarily on the diagnosis and treatment of glaucoma in leading medical journals. He has given over 400 invited lectures at worldwide medical forums in 45 countries. He currently publishes in the area of ophthalmic start-up business and development.
Dr. Stewart received his B.A. in Chemistry from Southern Methodist University and his medical degree from Southwestern Medical School in Dallas, Texas. After finishing a residency in ophthalmology at the University of Missouri at Kansas City, he completed a glaucoma fellowship at Duke University Medical Center under renowned glaucoma thought leader, Dr. M. Bruce Shields.
Jeanette A. Stewart, R.N.
PRN Pharmaceutical Research Network, LLC’s COO and Research Director is a Registered Nurse by training. Before co-founding PRN, Ms. Stewart focused on coordinating clinical trials in glaucoma, and then in developing and directing two separate clinical site management companies (SMOs), Charleston Research Company, LLC and Atlanta Research Company, LLC. Ms. Stewart is also co-founder of PRN PharmaFarm, LLC.
Currently, Ms. Stewart oversees day-to-day operations of PRN by assuring the quality of all aspects of the project team. In this capacity she has managed more than 70 research projects in the US, Australia, Canada, and throughout Europe. From her deep ophthalmic experience she has trained Project Managers, CRAs, clinical trial coordinators and site managers.
In addition, Ms. Stewart has assisted start-ups with everyday clinical operations. She is skilled in operational planning, protocol design, document control, timeline creation and management, labeling regulations, EDC development and implementation, and FDA document development (protocols, pre-IND briefing documents, INDs and Investigator Brochures). From the clinic to agency submissions, she consults and advises on all operational aspects of clinical development.
Ms. Stewart has published more than 100 scientific articles related to ophthalmic treatments and research processes. She has also presented at scientific meetings and as an invited lecturer.